Michael Adam Gordon

Filings by Michael Adam Gordon span 2 companies, the busiest being Lucid Diagnostics Inc. and PAVmed Inc. Between 7 May 2024 and 2 April 2026, the trades on record add up to 5 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

On 3 April 2026 came the latest disclosure, a share grant in PAVmed Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.